A clinical leader made legible to the market their company sells into
We gave the CMO a public position on safe adoption, which turned them into the reason clinical buyers took the first meeting and into the company's most requested voice at industry events.
- 7
- speaking invitations
- 3
- health system advisory groups
- 1
- national panel seat
A respected clinician inside a growing company, quoted only in press releases, with no independent public standing that a hospital board would recognise.
We separated the CMO's professional voice from the company's marketing voice and built a position on what safe adoption actually requires, including where their own category tends to fail.
Seven speaking invitations, three health system advisory groups and a national panel seat, all of which pulled the company into rooms its sales team could not reach.
- An independent professional voice, distinct from the brand.
- Willingness to name the category's real limitations in public.
- Speaking treated as a channel with a pack, a fee and a target list.
- Every appearance reused across sales and recruitment materials.
Clinicians nodded politely and never replied. Nine months later, four health systems opened the conversation themselves.
Every deal that moved had started with someone who already knew them. So we made far more people know them.
The deck was strong. The problem was that nobody had heard the argument behind it until the meeting started.